Kwok Leung Ong
Kwok Leung Ong
NHMRC Clinical Trials Centre, The University of Sydney
Verified email at
Cited by
Cited by
Prevalence, awareness, treatment, and control of hypertension among United States adults 1999–2004
KL Ong, BMY Cheung, YB Man, CP Lau, KSL Lam
Hypertension 49 (1), 69-75, 2007
Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006
BMY Cheung, KL Ong, SS Cherny, PC Sham, AWK Tso, KSL Lam
The American journal of medicine 122 (5), 443-453, 2009
Gender difference in blood pressure control and cardiovascular risk factors in Americans with diagnosed hypertension
KL Ong, AWK Tso, KSL Lam, BMY Cheung
Hypertension 51 (4), 1142-1148, 2008
Prevalence, treatment, and control of diagnosed diabetes in the US National Health and Nutrition Examination Survey 1999–2004
KL Ong, BMY Cheung, LYF Wong, NMS Wat, KCB Tan, KSL Lam
Annals of epidemiology 18 (3), 222-229, 2008
High plasma level of fibroblast growth factor 21 is an Independent predictor of type 2 diabetes: a 5.4-year population-based prospective study in Chinese subjects
C Chen, BMY Cheung, AWK Tso, Y Wang, LSC Law, KL Ong, NMS Wat, ...
Diabetes care 34 (9), 2113-2115, 2011
Urotensin II: its function in health and its role in disease
KL Ong, KSL Lam, BMY Cheung
Cardiovascular drugs and therapy 19, 65-75, 2005
Prevalence, awareness, treatment, and control of hypertension: United States national health and nutrition examination survey 2001–2002
BMY Cheung, KL Ong, YB Man, KSL Lam, CP Lau
The Journal of Clinical Hypertension 8 (2), 93-98, 2006
Obesity susceptibility genetic variants identified from recent genome-wide association studies: implications in a chinese population
CYY Cheung, AWK Tso, BMY Cheung, A Xu, KL Ong, CHY Fong, ...
The Journal of Clinical Endocrinology & Metabolism 95 (3), 1395-1403, 2010
Association of genetic variants in the adiponectin gene with adiponectin level and hypertension in Hong Kong Chinese
KL Ong, M Li, AWK Tso, A Xu, SS Cherny, PC Sham, HF Tse, TH Lam, ...
European journal of endocrinology 163 (2), 251-257, 2010
Fibroblast growth factor 21 in non-alcoholic fatty liver disease
B Tucker, H Li, X Long, KA Rye, KL Ong
Metabolism 101, 153994, 2019
Arthritis: its prevalence, risk factors, and association with cardiovascular diseases in the United States, 1999 to 2008
KL Ong, BJ Wu, BMY Cheung, PJ Barter, KA Rye
Annals of epidemiology 23 (2), 80-86, 2013
Circulating microRNAs as biomarkers of Alzheimer’s disease: a systematic review
HZY Wu, KL Ong, K Seeher, NJ Armstrong, A Thalamuthu, H Brodaty, ...
Journal of Alzheimer's Disease 49 (3), 755-766, 2016
High-density lipoproteins inhibit vascular endothelial inflammation by increasing 3β-hydroxysteroid-Δ24 reductase expression and inducing heme oxygenase-1
BJ Wu, K Chen, S Shrestha, KL Ong, PJ Barter, KA Rye
Circulation research 112 (2), 278-288, 2013
APOA1: a protein with multiple therapeutic functions
BJ Cochran, KL Ong, B Manandhar, KA Rye
Current Atherosclerosis Reports 23, 1-10, 2021
The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study
KL Ong, AS Januszewski, R O’Connell, AJ Jenkins, A Xu, DR Sullivan, ...
Diabetologia 58, 464-473, 2015
Elevated serum alkaline phosphatase and peripheral arterial disease in the United States National Health and Nutrition Examination Survey 1999–2004
BMY Cheung, KL Ong, LYF Wong
International journal of cardiology 135 (2), 156-161, 2009
Long-term fenofibrate therapy increases fibroblast growth factor 21 and retinol-binding protein 4 in subjects with type 2 diabetes
KL Ong, KA Rye, R O'Connell, AJ Jenkins, C Brown, A Xu, DR Sullivan, ...
The Journal of Clinical Endocrinology & Metabolism 97 (12), 4701-4708, 2012
Haplotypes in the urotensin II gene and urotensin II receptor gene are associated with insulin resistance and impaired glucose tolerance
KL Ong, LYF Wong, YB Man, RYH Leung, YQ Song, KSL Lam, ...
Peptides 27 (7), 1659-1667, 2006
The role of fibroblast growth factor 21 in atherosclerosis
J Kokkinos, S Tang, KA Rye, KL Ong
Atherosclerosis 257, 259-265, 2017
Plasma level of pigment epithelium-derived factor is independently associated with the development of the metabolic syndrome in Chinese men: a 10-year prospective study
C Chen, AWK Tso, LSC Law, BMY Cheung, KL Ong, NMS Wat, ED Janus, ...
The Journal of Clinical Endocrinology & Metabolism 95 (11), 5074-5081, 2010
The system can't perform the operation now. Try again later.
Articles 1–20